Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib plus cyclophosphamide and dexamethasone in newly diagnosed or relapsed/refractory multiple myeloma
2013-003113-17Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixazomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Primary endpoint: Primary endpoints (NDMM). Started Nov 2013; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2013-003113-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003113-17.